Annual CFI
$7.77 M
+$4.26 M+121.53%
December 1, 2024
Summary
- As of March 9, 2025, ARTL annual cash flow from investing activities is $7.77 million, with the most recent change of +$4.26 million (+121.53%) on December 1, 2024.
- During the last 3 years, ARTL annual CFI has risen by +$17.80 million (+177.43%).
- ARTL annual CFI is now at all-time high.
Performance
ARTL Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$500.00 K
-$3.75 M-88.24%
December 1, 2024
Summary
- As of March 9, 2025, ARTL quarterly cash flow from investing activities is $500.00 thousand, with the most recent change of -$3.75 million (-88.24%) on December 1, 2024.
- Over the past year, ARTL quarterly CFI has dropped by -$1.25 million (-71.43%).
- ARTL quarterly CFI is now -88.24% below its all-time high of $4.25 million, reached on September 1, 2024.
Performance
ARTL Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$7.77 M
-$2.24 M-22.39%
December 1, 2024
Summary
- As of March 9, 2025, ARTL TTM cash flow from investing activities is $7.77 million, with the most recent change of -$2.24 million (-22.39%) on December 1, 2024.
- Over the past year, ARTL TTM CFI has increased by +$3.84 million (+97.79%).
- ARTL TTM CFI is now -22.39% below its all-time high of $10.01 million, reached on September 1, 2024.
Performance
ARTL TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ARTL Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +121.5% | -71.4% | +97.8% |
| 3 y3 years | +177.4% | +105.6% | +163.1% |
| 5 y5 years | +100.0% | +100.0% | +100.0% |
ARTL Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +177.4% | -88.2% | +116.2% | -22.4% | +167.3% |
| 5 y | 5-year | at high | +177.4% | -88.2% | +105.6% | -22.4% | +163.1% |
| alltime | all time | at high | +177.4% | -88.2% | +105.6% | -22.4% | +163.1% |
Artelo Biosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $7.77 M(+121.5%) | $500.00 K(-88.2%) | $7.77 M(-22.4%) |
| Sep 2024 | - | $4.25 M(+142.9%) | $10.01 M(+154.8%) |
| Jun 2024 | - | $1.75 M(+37.9%) | $3.93 M(+52.4%) |
| Mar 2024 | - | $1.27 M(-53.7%) | $2.58 M(-26.5%) |
| Dec 2023 | $3.51 M(+18.6%) | $2.74 M(-249.6%) | $3.51 M(+36.9%) |
| Sep 2023 | - | -$1.83 M(-559.1%) | $2.56 M(+95.0%) |
| Jun 2023 | - | $399.00 K(-81.9%) | $1.31 M(-73.2%) |
| Mar 2023 | - | $2.20 M(+22.4%) | $4.90 M(+65.7%) |
| Dec 2022 | $2.96 M(-129.5%) | $1.80 M(-158.3%) | $2.96 M(-138.3%) |
| Sep 2022 | - | -$3.08 M(-177.3%) | -$7.72 M(-4.4%) |
| Jun 2022 | - | $3.98 M(+1450.6%) | -$8.07 M(-30.1%) |
| Mar 2022 | - | $257.00 K(-102.9%) | -$11.55 M(-6.2%) |
| Dec 2021 | -$10.03 M(+191.7%) | - | - |
| Nov 2021 | - | -$8.88 M(+158.2%) | -$12.32 M(+258.2%) |
| Aug 2021 | -$3.44 M(<-9900.0%) | -$3.44 M(-773.4%) | -$3.44 M(<-9900.0%) |
| May 2021 | - | $510.70 K(-200.0%) | $1200.00(-100.2%) |
| Feb 2021 | - | -$510.70 K(<-9900.0%) | -$509.50 K(<-9900.0%) |
| Nov 2020 | - | $0.00(-100.0%) | $0.00(0.0%) |
| Aug 2020 | $0.00 | $1200.00(>+9900.0%) | $0.00(-100.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| May 2020 | - | $0.00(-100.0%) | -$1.50 M(-0.0%) |
| Feb 2020 | - | -$1200.00(-99.9%) | -$1.50 M(+0.1%) |
| Aug 2019 | -$1.50 M(>+9900.0%) | -$1.50 M(>+9900.0%) | -$1.50 M(>+9900.0%) |
| May 2019 | - | -$700.00(<-9900.0%) | -$700.00(<-9900.0%) |
| Feb 2019 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Aug 2018 | -$800.00(<-9900.0%) | $0.00(0.0%) | -$900.00(0.0%) |
| May 2018 | - | $0.00(0.0%) | -$900.00(0.0%) |
| Feb 2018 | - | $0.00(-100.0%) | -$900.00(0.0%) |
| Nov 2017 | - | -$900.00(<-9900.0%) | -$900.00(<-9900.0%) |
| Aug 2017 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| May 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2015 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2014 | - | $0.00 | $0.00 |
| Aug 2014 | $0.00 | - | - |
FAQ
- What is Artelo Biosciences annual cash flow from investing activities?
- What is the all time high annual CFI for Artelo Biosciences?
- What is Artelo Biosciences annual CFI year-on-year change?
- What is Artelo Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Artelo Biosciences?
- What is Artelo Biosciences quarterly CFI year-on-year change?
- What is Artelo Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Artelo Biosciences?
- What is Artelo Biosciences TTM CFI year-on-year change?
What is Artelo Biosciences annual cash flow from investing activities?
The current annual CFI of ARTL is $7.77 M
What is the all time high annual CFI for Artelo Biosciences?
Artelo Biosciences all-time high annual cash flow from investing activities is $7.77 M
What is Artelo Biosciences annual CFI year-on-year change?
Over the past year, ARTL annual cash flow from investing activities has changed by +$4.26 M (+121.53%)
What is Artelo Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of ARTL is $500.00 K
What is the all time high quarterly CFI for Artelo Biosciences?
Artelo Biosciences all-time high quarterly cash flow from investing activities is $4.25 M
What is Artelo Biosciences quarterly CFI year-on-year change?
Over the past year, ARTL quarterly cash flow from investing activities has changed by -$1.25 M (-71.43%)
What is Artelo Biosciences TTM cash flow from investing activities?
The current TTM CFI of ARTL is $7.77 M
What is the all time high TTM CFI for Artelo Biosciences?
Artelo Biosciences all-time high TTM cash flow from investing activities is $10.01 M
What is Artelo Biosciences TTM CFI year-on-year change?
Over the past year, ARTL TTM cash flow from investing activities has changed by +$3.84 M (+97.79%)